UY28917A1 - Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico - Google Patents

Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico

Info

Publication number
UY28917A1
UY28917A1 UY28917A UY28917A UY28917A1 UY 28917 A1 UY28917 A1 UY 28917A1 UY 28917 A UY28917 A UY 28917A UY 28917 A UY28917 A UY 28917A UY 28917 A1 UY28917 A1 UY 28917A1
Authority
UY
Uruguay
Prior art keywords
tetrahydroisoquinolilsulfonamids
derivatives
pharmaceutical compositions
therapeutic use
therapeutic
Prior art date
Application number
UY28917A
Other languages
English (en)
Inventor
Juan Antonio Diaz Martin
Maria Dolores Jimenez Bargueno
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34944870&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY28917(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY28917A1 publication Critical patent/UY28917A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/472—Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

Compuesto que responde a la fórmula I; en la cual: n, -(C) n-, R1, R2, B, R3, R4 son como se definieron en la memoria descriptiva y reivindicaciones, de aplicación terapéutica.
UY28917A 2004-05-25 2005-05-24 Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico UY28917A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0405607A FR2870846B1 (fr) 2004-05-25 2004-05-25 Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique

Publications (1)

Publication Number Publication Date
UY28917A1 true UY28917A1 (es) 2005-12-30

Family

ID=34944870

Family Applications (1)

Application Number Title Priority Date Filing Date
UY28917A UY28917A1 (es) 2004-05-25 2005-05-24 Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico

Country Status (41)

Country Link
US (3) US7833999B2 (es)
EP (1) EP1753725B1 (es)
JP (1) JP4861979B2 (es)
KR (1) KR101176675B1 (es)
CN (1) CN1956962B (es)
AR (1) AR050250A1 (es)
AU (1) AU2005250197B2 (es)
BR (1) BRPI0511581A (es)
CA (1) CA2565293C (es)
CR (1) CR8735A (es)
CY (1) CY1114240T1 (es)
DK (1) DK1753725T3 (es)
DO (1) DOP2005000103A (es)
EA (1) EA010234B1 (es)
EC (1) ECSP067020A (es)
ES (1) ES2407140T3 (es)
FR (1) FR2870846B1 (es)
GT (1) GT200500126A (es)
HK (1) HK1106229A1 (es)
HN (1) HN2005000239A (es)
HR (1) HRP20130431T1 (es)
IL (1) IL179021A (es)
JO (1) JO2877B1 (es)
MA (1) MA28720B1 (es)
MX (1) MXPA06013629A (es)
MY (1) MY148980A (es)
NI (1) NI200600279A (es)
NO (1) NO338104B1 (es)
NZ (1) NZ551509A (es)
PA (1) PA8634501A1 (es)
PE (1) PE20060273A1 (es)
PL (1) PL1753725T3 (es)
PT (1) PT1753725E (es)
SI (1) SI1753725T1 (es)
SV (1) SV2006002126A (es)
TN (1) TNSN06356A1 (es)
TW (1) TWI360540B (es)
UA (1) UA84771C2 (es)
UY (1) UY28917A1 (es)
WO (1) WO2005118547A1 (es)
ZA (1) ZA200609820B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2870846B1 (fr) * 2004-05-25 2006-08-04 Sanofi Synthelabo Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique
EP1790646A1 (fr) * 2005-11-24 2007-05-30 Sanofi-Aventis Derives de Isoquinoline et Benzo[h]Isoquinoline, leur preparation et leur utilisation en thérapeutique en tant qu'antagonistes du recepteur de l'histamine H3.
WO2009063953A1 (ja) 2007-11-13 2009-05-22 Taisho Pharmaceutical Co., Ltd. フェニルピラゾール誘導体
TW201039822A (en) 2009-02-06 2010-11-16 Taisho Pharmaceutical Co Ltd Dihydroquinolinone derivatives
EP2445899B1 (en) 2009-06-26 2016-05-11 Sanofi Novel fumarate salts of a histamine h3 receptor antagonist
AR080374A1 (es) * 2010-03-05 2012-04-04 Sanofi Aventis Procedimiento para la preparcion de 2-(ciclohexilmetil)-n-(2-((2s)-1-metilpirrolidin-2-il) etil)- 1,2,3,4-tetrahidroisoquinolin-7- sulfonamida
WO2013085018A1 (ja) 2011-12-08 2013-06-13 大正製薬株式会社 フェニルピロール誘導体
US20150045553A1 (en) 2011-12-27 2015-02-12 Taisho Pharmaceutical Co., Ltd Phenyltriazole derivative
EP2647377A1 (en) 2012-04-06 2013-10-09 Sanofi Use of an h3 receptor antagonist for the treatment of alzheimer's disease
WO2015032966A1 (en) * 2013-09-09 2015-03-12 Sanofi An h3 receptor antagonist combined with a cholinesterase inhibitor for use in the treatment of alzheimer's disease
CN110642854A (zh) * 2019-11-20 2020-01-03 成都克莱蒙医药科技有限公司 一种稠环化合物的多晶型、其组合物、制备方法及其应用
WO2022113008A1 (en) 2020-11-27 2022-06-02 Richter Gedeon Nyrt. Histamine h3 receptor antagonists/inverse agonists for the treatment of autism spectrum disorder

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0702671A4 (en) * 1993-06-09 1996-06-19 Smithkline Beecham Corp BICYCLIC FIBRINOGEN ANTAGONISTS
GB9508622D0 (en) * 1995-04-28 1995-06-14 Pfizer Ltd Therapeutic agants
NZ331272A (en) * 1996-02-09 2000-01-28 Black James Foundation Histamine H3 receptor ligands
IL138899A0 (en) 1998-04-10 2001-11-25 Japan Tobacco Inc Amidene derivatives and pharmaceutical compositions containing the same
US6545055B1 (en) 1999-05-24 2003-04-08 Millennium Pharmaceuticals, Inc. Inhibitors of factor Xa
JP4031363B2 (ja) 2001-01-02 2008-01-09 エフ．ホフマン−ラ ロシュ アーゲー α−１Ａ／Ｂアドレナリン作動性受容体拮抗薬としてのキナゾロン誘導体
AU2002254114A1 (en) * 2001-03-23 2002-10-08 Eli Lilly And Company Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses
JP2003192660A (ja) * 2001-12-26 2003-07-09 Bayer Ag 尿素誘導体
US20050154230A1 (en) * 2001-12-26 2005-07-14 Bayer Healthcare Ag Urea derivatives
KR100984655B1 (ko) 2002-03-08 2010-10-01 사카타 인쿠스 가부시키가이샤 처리안료, 그 용도 및 안료처리용 화합물
GB0206033D0 (en) 2002-03-14 2002-04-24 Pfizer Ltd Compounds useful in therapy
BR0313923A (pt) * 2002-08-29 2005-07-12 Boehringer Ingelheim Pharma Derivados de 3-(sulfonamidoetil)-indol para uso como miméticos de glicocorticóide no tratamento de doenças inflamatórias, alérgicas e proliferativas
US7598412B2 (en) 2003-10-08 2009-10-06 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
US20070099938A1 (en) 2003-10-24 2007-05-03 Ono Pharmaceutical Co., Ltd. Antistress drug and medical use thereof
FR2870846B1 (fr) * 2004-05-25 2006-08-04 Sanofi Synthelabo Derives de tetrahydroisoquinolylsulfonamides, leur preparation et leur utilisation en therapeutique
EP1630158A1 (en) 2004-08-18 2006-03-01 Laboratorios Del Dr. Esteve, S.A. 5-HT7 receptor antagonists
ES2257168B1 (es) 2004-08-18 2007-06-01 Laboratorios Del Dr Esteve, S.A. Ligandos del receptor 5-ht7.
US20080261999A1 (en) 2005-03-04 2008-10-23 Fionna Mitchell Martin Azabicycloalkane Derivatives Useful as Nicotinic Acetylcholine Receptor Agonists
EP1790646A1 (fr) * 2005-11-24 2007-05-30 Sanofi-Aventis Derives de Isoquinoline et Benzo[h]Isoquinoline, leur preparation et leur utilisation en thérapeutique en tant qu'antagonistes du recepteur de l'histamine H3.

Also Published As

Publication number Publication date
CN1956962B (zh) 2014-08-20
ECSP067020A (es) 2006-12-29
WO2005118547A1 (fr) 2005-12-15
FR2870846B1 (fr) 2006-08-04
NI200600279A (es) 2008-01-22
US20120323003A1 (en) 2012-12-20
TW200609220A (en) 2006-03-16
ES2407140T3 (es) 2013-06-11
MA28720B1 (fr) 2007-07-02
DOP2005000103A (es) 2006-02-15
US20110028475A1 (en) 2011-02-03
FR2870846A1 (fr) 2005-12-02
JO2877B1 (en) 2015-03-15
CA2565293A1 (fr) 2005-12-15
CN1956962A (zh) 2007-05-02
NO338104B1 (no) 2016-08-01
NZ551509A (en) 2009-12-24
AR050250A1 (es) 2006-10-11
US7833999B2 (en) 2010-11-16
CY1114240T1 (el) 2016-08-31
US8273733B2 (en) 2012-09-25
KR20070021223A (ko) 2007-02-22
HRP20130431T1 (en) 2013-06-30
GT200500126A (es) 2006-02-17
IL179021A (en) 2012-04-30
MXPA06013629A (es) 2007-03-23
EA200602176A1 (ru) 2007-04-27
CR8735A (es) 2007-08-28
JP2008500313A (ja) 2008-01-10
ZA200609820B (en) 2008-06-25
PA8634501A1 (es) 2006-05-16
CA2565293C (fr) 2012-10-30
DK1753725T3 (da) 2013-05-27
MY148980A (en) 2013-06-28
AU2005250197A1 (en) 2005-12-15
BRPI0511581A (pt) 2008-01-02
UA84771C2 (uk) 2008-11-25
EA010234B1 (ru) 2008-06-30
US20070105834A1 (en) 2007-05-10
EP1753725B1 (fr) 2013-02-27
NO20065918L (no) 2006-12-19
AU2005250197B2 (en) 2010-09-23
SI1753725T1 (sl) 2013-06-28
JP4861979B2 (ja) 2012-01-25
PL1753725T3 (pl) 2013-07-31
EP1753725A1 (fr) 2007-02-21
IL179021A0 (en) 2007-03-08
TNSN06356A1 (en) 2008-02-22
KR101176675B1 (ko) 2012-08-23
PE20060273A1 (es) 2006-04-22
HN2005000239A (es) 2009-04-27
PT1753725E (pt) 2013-05-21
SV2006002126A (es) 2006-01-13
HK1106229A1 (en) 2008-03-07
TWI360540B (en) 2012-03-21
US8524700B2 (en) 2013-09-03

Similar Documents

Publication Publication Date Title
UY28917A1 (es) Derivados de tetrahidroisoquinolilsulfonamidas composiciones farmaceuticas y su uso terapeutico
UY29112A1 (es) Derivados de pirazol condensado, su preparacion y su aplicacion terapeutica
BRPI0717266A2 (pt) Derivados de oxindol
UY31183A1 (es) Derivados de pirazinona y procesos para su preparación
BRPI0716171A8 (pt) Composto, composição farmacêutica e uso de um composto
UY29963A1 (es) Compuestos terapéuticos: piridinas y pirazinas como andamios
BRPI0715579A2 (pt) "composto, composição farmacêutica e uso de um composto"
EA201070519A1 (ru) Соединения тропана
BR112012018345A2 (pt) "compostos de heteroarila, bem como composições e usos dos mesmos"
BRPI0915084B8 (pt) composto, e, composição farmacêutica
NO20083630L (no) Nye pyridinderivater
BRPI0513184A (pt) derivados de 2-carbamida-4-feniltiazol, preparação dos mesmos e aplicação dos mesmos em terapia
UY29041A1 (es) Derivados de amino-piperidina, su preparacion y su utilización en terapeutica
UY29795A1 (es) Derivados de adenina, composiciones farmacéuticas que los contienen, procesos de preparación y aplicaciones
ECSP099177A (es) Derivados de quinazolinona e isoquinolinona
CR10243A (es) "bencimidazoles 2-sustituidos como modulares de receptor de androgeno selectivos"
UY29486A1 (es) Compuestos utiles en terapia
UY29373A1 (es) Derivados del 1,5-diarilpirrol, su preparación y su aplicación en terapeutica
MXPA06000921A (es) Derivados de benzamidazoles como inhibidores de mek.
EA201170703A1 (ru) Производные адамантилбензамида
CR10603A (es) Derivados de 5,6-bisaril-2-piridin-carboxamida, su preparacion y su aplicacion en terapeutica como antagonistas de los receptores de urotensina ii
PA8779801A1 (es) Derivados heterocíclicos sustituidos y su uso farmacéutico y composiciones
MA32979B1 (fr) Derives aminoesterifies d'alcaloides et composition medicinale les incluant
GT200900309A (es) Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica
UY29892A1 (es) Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160518